RVL Pharmaceuticals plc Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- RVL Pharmaceuticals plc payments for repurchase of common stock for the quarter ending 2020-12-31 was $3.27M, a 125.40% increase year-over-year.
- RVL Pharmaceuticals plc payments for repurchase of common stock for the quarter ending 2020-09-30 was $3.75M.
- RVL Pharmaceuticals plc payments for repurchase of common stock for the quarter ending 2020-06-30 was $919.00K.
- RVL Pharmaceuticals plc payments for repurchase of common stock for the quarter ending 2020-03-31 was $167.00K.
- RVL Pharmaceuticals plc payments for repurchase of common stock for fiscal 2020 was $8.10M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2020-12-31 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $8.10M 10-K · filed 2022-03-30 |
| 2020-09-30 | $3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $6.28M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $919.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | |
| 2020-03-31 | $167.00K 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $1.45M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | $2.79M 8-K · filed 2021-09-08 |